Campbell & CO Investment Adviser LLC

Position in LLY — ELI LILLY & Co

CIK 1353570 BALTIMORE, MD

Position in LLY

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$6,476,100

+$3,305,794 QoQ

Shares Held

7,041

+138.7% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Campbell & CO Investment Adviser LLC holds $29,502,691 across 9 Drug Manufacturers - General names. LLY ranks #2 (22.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	50,560	$7,046,547
2	LLY	ELI LILLY & Co This page	7,041	$6,476,100
3	NVS	Novartis AG	39,646	$6,055,926
4	AMGN	Amgen Inc	14,110	$4,964,603
5	BMY	Bristol Myers Squibb Co	29,424	$1,784,565
6	AZN	Astrazeneca PLC	8,338	$1,644,420
7	OGN	Organon & Co.	128,309	$768,570
8	GRFS	Grifols SA	63,848	$512,060

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,476,100	7,041	+138.7%	Shares	Sole	2026-05-15
2025-12-31	$3,170,306	2,950	-14.0%	Shares	Sole	2026-02-12
2025-09-30	$2,618,616	3,432	+153.1%	Shares	Sole	2025-10-28
2025-03-31	$1,119,933	1,356	+78.9%	Shares	Sole	2025-05-14
2024-09-30	$671,542	758	-92.3%	Shares	Sole	2024-11-12
2024-06-30	$8,884,493	9,813	+915.8%	Shares	Sole	2024-08-13
2024-03-31	$751,509	966	+122.1%	Shares	Sole	2024-05-10
2023-09-30	$233,651	435	-57.7%	Shares	Sole	2023-11-08
2022-06-30	$333,632	1,029	-86.8%	Shares	Sole	2022-08-09
2022-03-31	$2,225,667	7,772	+10.9%	Shares	Sole	2022-05-09
2021-09-30	$1,619,660	7,010	+240.3%	Shares	Sole	2021-11-10
2021-03-31	$384,849	2,060	—	Shares	Sole	2021-05-14
No filing history on record for this holder in this stock.